VanEck Vectors Financial Indicators Patterns

BBH -- USA Etf  

USD 118.55  0.15  0.13%

Use fundamental data analysis to confirm all available indicators of VanEck Vectors Biotech to find out if markets are presently mispricing the entity. We found eleven available drivers for VanEck Vectors Biotech ETF which can be compared to its competition. Please use VanEck Vectors One Year Return and Net Asset to make a decision on weather VanEck Vectors Biotech is priced fairly. Use VanEck Vectors to enhance returns of your portfolios. The etf experiences normal upward fluctuation. Check odds of VanEck Vectors to be traded at $124.48 in 30 days

VanEck Vectors Company Summary

VanEck Vectors competes with iShares Nasdaq, First Trust, ARK Genomic, VanEck Vectors, and PowerShares Dynamic. The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index. VanEck Vectors is traded on NASDAQ General Markets in USA.

VanEck Vectors One Year Return vs Five Year Return

VanEck Vectors Biotech ETF is rated below average in one year return as compared to similar ETFs. It is fourth largest ETF in five year return as compared to similar ETFs .

VanEck Vectors Biotech Systematic Risk

The output start index for this execution was twelve with a total number of output elements of twenty-seven. The Beta measures systematic risk based on how returns on VanEck Vectors Biotech correlated with the market. If Beta is less than 0 VanEck Vectors generally moves in the opposite direction as compared to the market. If VanEck Vectors Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one VanEck Vectors Biotech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of VanEck Vectors is generally in the same direction as the market. If Beta > 1 VanEck Vectors moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

Distress Rating

VanEck Vectors Financial Distress Probability

26%
Chance of Financial Distress
VanEck Vectors Biotech ETF has less than 26 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Compare VanEck Vectors

Compare VanEck Vectors To Peers

VanEck Vectors Opportunity Range

December 11, 2018 Opportunity Range

Check also Trending Equities. Please also try Theme Ratings module to determine theme ratings based on digital equity recommendations. macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Search macroaxis.com